FOLH1 and neoplasm: Recent work by Basilion and co-workers has shown that PSMA-targeted gold nanoclusters have a high tumor selectivity, excellent renal clearance with 14% ID/g Au excreted in urine at 24 h post-injection, and two times less retention in liver compared to the AuNPs counterpart as revealed by ICP and CT imaging [97].